Skip to content

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Other financials

Income statement

See full
Revenue$44.3M-20.2%
Gross profit$6.7M-50.6%
Operating income-$6.4M-21.4%
Net income-$15.8M-2.0%
EPS (diluted)-$0.61-8.9%

Balance sheet

See full
Cash & equivalents$38.7M-9.9%
Total debt$328.4M-4.4%
Total equity$247.5M-12.8%
Total assets$640.7M-7.7%

Cash flow

See full
Operating cash flow-$15.1M-32.0%
CapEx$6.1M-70.7%
Free cash flow-$21.2M+34.2%

Valuation

See full
Market cap$205.4M+43.2%
Enterprise value$495.07M+9.7%
P/S+0.4×

Profitability

See full
Gross margin18.1%-9.5pp
Operating margin0.6%-0.3pp
Net margin-13%-4.4pp
FCF margin-34.2%

Returns & leverage

See full
Return on equity-10.6%-3.6pp
Debt / equity1.3×+0.1×
Current ratio2.4×+0.5×